Table 2.
SSS and VAS scores of dysmenorrhea before and 3, 6 and 12 months after HIFU ablation
| Pre-treatment (n=51) | 3 m post-treatment (n=51) | 6 m post-treatment (n=47) | 12 m post-treatment (n=47) | |
|---|---|---|---|---|
| Total SSS | 36.66±19.44 | 24.60±13.88 | 18.18±11.63*** | 12.95±10.31*** |
| Heavy menstrual bleeding | 7.25±3.72 | 5.0±2.92* | 3.61±2.52*** | 2.57±2.23*** |
| Blood clotting | 5.99±3.85 | 3.85±2.75* | 2.66±2.18*** | 1.66±1.58*** |
| Fluctuation of menses durations | 4.22±3.92 | 2.76±2.41 | 2.01±1.75** | 1.51±1.4*** |
| Fluctuations of menses intervals | 3.52±3.23 | 2.25±1.93 | 1.66±1.34** | 1.23±1.14*** |
| Pelvic tightness/pressure | 8.34±2.61 | 5.01±2.18*** | 3.44±2.01***,▲ | 2.46±2.04*** |
| Daytime urination | 1.99±1.31 | 1.49±0.7 | 1.35±0.94*** | 0.97±0.6*** |
| Nighttime urination | 1.72±0.46 | 1.42±0.52 | 1.29±0.85*** | 0.93±0.55*** |
| Fatigue | 3.63±2.47 | 2.82±2.08 | 2.16±1.76** | 1.62±1.42*** |
| Dysmenorrheal VAS | 6.67± 1.6 | 4.75 ±1.7*** | 3.10±1.26***,▲▲ | 1.86±1.18*** |
*
P<0.05 compared to pre-treatment scores;
**
P<0.01 compared to pre-treatment scores;
***
P<0.001 compared to pre-treatment scores;
▲
P<0.05 compared to scores of the last previous follow up;
▲▲
P<0.01 compared to scores of the last previous follow up.